You searched for metabolic diseases - Page 19 of 64

News and Trends 3 Mar 2023

Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor

…09 is a novel metabolic immune checkpoint inhibitor, for the treatment of patients with hematological malignancies who are diagnosed with a relapse after allogeneic stem cell transplant (SCT). LR 09…

March 3, 2023 - 3 minutesmins - By Jim Cornall

Podcast 16 Feb 2024

How does AI help drug discovery?

…with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases….

February 16, 2024 - 10 minutesmins - By Jim Cornall

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

…undisclosed targets for the treatment of other neuromuscular diseases, hence expanding its pipeline. The financing was led by investment company Jeito Capital, and other investors that took part include Novo…

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…leverage FANA technology in cancer immunotherapy and other therapeutic areas. AUM LifeTech’s pipeline focuses on developing RNA silencing therapies for a variety of genetically defined diseases. The company also has…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 18 Jul 2023

Korro Bio and Frequency Therapeutics to merge

…the potential to advance genetic medicines beyond rare genetic diseases into larger patient populations with common diseases. About OPERA Korro Bio’s platform, OPERA (oligonucleotide promoted editing of RNA), builds on…

July 18, 2023 - 7 minutesmins - By Jim Cornall

Best in Biotech 27 Feb 2024

Japan’s ten hottest biotech companies in healthcare

…disease and type 2 diabetes. For this reason, the Japanese healthcare authorities are encouraging research into the treatment and prevention of these diseases, in addition to promoting the potential of…

February 27, 2024 - 12 minutesmins - By Jules Adam

News and Trends 19 Jan 2023

Hundreds of genetic discoveries from FinnGen study

New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases. These findings have potential to facilitate the development of new therapies. Since initiation…

January 19, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 17 Apr 2023

Aer Therapeutics raises $36M to tackle lung diseases

Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) biopharmaceutical spin-out company developing novel inhaled treatments for muco-obstructive lung diseases, has announced the closing…

April 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 22 Aug 2022

Vaderis emerges from stealth to start HTT trial

…the serine kinase AKT, resulting in vascular overgrowth. Such diseases frequently manifest in ways that are debilitating, disfiguring, painful and sometimes life-threatening. The vast majority of these diseases are currently…

August 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 20 Feb 2018

Microsoft Joins Shire to Diagnose Rare Diseases Much Faster

…There are over 6,000 different rare diseases, most of them beginning in childhood. However, diagnosing them takes an average of 5 years, delaying the start of the necessary treatments and…

February 20, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 May 2016

Biotech of the Week: Avexxin, reducing inflammatory diseases from far up in Norway

…and chronic diseases. Avexxin’s current pipeline includes compounds against psoriasis and related autoimmune diseases, including rheumatoid arthritis and glomerulonephritis (Kidneys). They have even been previously tested and proven successful against…

May 13, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 14 Sep 2022

SparingVision raises €75M for genomic medicines for ocular diseases

SparingVision, a genomic medicine company developing vision-saving treatments for ocular diseases, has raised €75 million ($75 million) in series B financing. The round was co-led by Jeito Capital and UPMC…

September 14, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor

How does AI help drug discovery?

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Eight companies spearheading Philadelphia’s biotech industry

Korro Bio and Frequency Therapeutics to merge

Japan’s ten hottest biotech companies in healthcare

Hundreds of genetic discoveries from FinnGen study

Aer Therapeutics raises $36M to tackle lung diseases

Vaderis emerges from stealth to start HTT trial

Microsoft Joins Shire to Diagnose Rare Diseases Much Faster

Biotech of the Week: Avexxin, reducing inflammatory diseases from far up in Norway

SparingVision raises €75M for genomic medicines for ocular diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!